Binding Mechanism of CD47 with SIRPα Variants and Its Antibody: Elucidated by Molecular Dynamics Simulations
The intricate complex system of the differentiation 47 (CD47) and the signal-regulatory protein alpha (SIRPα) cluster is a crucial target for cancer immunotherapy. Although the conformational state of the CD47-SIRPα complex has been revealed through crystallographic studies, further characterization...
Main Authors: | Kaisheng Huang, Yi Liu, Shuixiu Wen, Yuxin Zhao, Hanjing Ding, Hui Liu, De-Xin Kong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/12/4610 |
Similar Items
-
Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade
by: Abdullahi Alausa, et al.
Published: (2022-07-01) -
Cancer Therapy Targeting CD47/SIRPα
by: Nazli Dizman, et al.
Published: (2021-12-01) -
Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma
by: Amy Xiao, et al.
Published: (2022-11-01) -
Membrane-Mediated Cooperative Interactions of CD47 and SIRP<i>α</i>
by: Long Li, et al.
Published: (2023-11-01) -
Molecular mechanics and dynamics simulation of CD-47/SIRPα blockade study: A computational study on overcoming immunotherapeutic resistance in pancreatic ductal adenocarcinoma
by: Oluwatosin A. Saibu, et al.
Published: (2023-11-01)